<- Go Home
Physiomics Plc
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Market Cap
GBP 1.1M
Volume
4.8M
Cash and Equivalents
GBP 461.2K
EBITDA
-GBP 446.3K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-GBP 435.1K
Profit Margin
52.16%
52 Week High
GBP 0.01
52 Week Low
GBP 0.00
Dividend
N/A
Price / Book Value
1.64
Price / Earnings
-2.15
Price / Tangible Book Value
1.65
Enterprise Value
GBP 675.8K
Enterprise Value / EBITDA
-1.51
Operating Income
-GBP 455.4K
Return on Equity
85.21%
Return on Assets
-43.30
Cash and Short Term Investments
GBP 461.2K
Debt
N/A
Equity
GBP 692.2K
Revenue
GBP 834.2K
Unlevered FCF
-GBP 415.1K
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium